Morphine is a naturally occurring opioid drug obtained from opium, the dried latex of the opium poppy. Its principal medical action is analgesia—the relief of pain. It is used in surgical, cancer, emergency, and palliative care, but can also cause life-threatening respiratory depression and has a substantial potential for misuse and addiction. (dea.gov)
Chemical identity and origin
Morphine belongs to the alkaloids, a group of naturally occurring nitrogen-containing compounds. Its molecular formula is . Pharmaceutical preparations commonly contain a salt, such as morphine sulfate, rather than the free base; the salt and the active morphine molecule are chemically distinct forms of the medicine. (pubchem.ncbi.nlm.nih.gov)
The isolation of morphine from opium is associated with Friedrich Sertürner’s work in the early nineteenth century. Separating an active constituent from a plant preparation made more standardized administration possible and was an important development in pharmacology. Morphine subsequently became a reference drug against which other strong analgesics were compared. (pmc.ncbi.nlm.nih.gov)
Pharmacological action
Morphine is a full opioid-receptor agonist, acting principally at the mu-opioid receptor. Opioid receptors in the brain and spinal cord participate in its analgesic effects. Morphine alters pain processing rather than removing the underlying cause of pain. Its effects on the central nervous system can also include sedation and euphoria. (dailymed.nlm.nih.gov)
The same pharmacological activity that produces analgesia can suppress breathing. Morphine acts on brainstem respiratory centers, reducing their responsiveness to rising carbon dioxide levels. It also slows gastrointestinal propulsion, contributing to constipation, and commonly constricts the pupils. Increasing exposure can increase both analgesia and adverse effects; the absence of a fixed analgesic ceiling does not imply that escalating exposure is safe. (dailymed.nlm.nih.gov)
Medical uses and formulations
Morphine is used for pain severe enough to require an opioid when other treatments are inadequate. Clinical settings include pain following surgery, pain associated with cancer, and palliative care. It also has a role in treating severe breathlessness refractory to treatment of the underlying cause, particularly near the end of life. This use is distinct from treating the underlying respiratory disease itself. (dailymed.nlm.nih.gov)
Available pharmaceutical forms include oral solutions, immediate-release tablets, extended-release tablets or capsules, and injectable preparations. Immediate-release and extended-release products differ in how quickly they deliver morphine; formulations and routes are not interchangeable solely on the basis of their stated mass. Extended-release preparations are designed to deliver the drug over a longer period. (dea.gov)
Absorption, metabolism, and elimination
Oral morphine undergoes substantial metabolism before reaching the systemic circulation, producing lower and more variable bioavailability than administration directly into the bloodstream. Its metabolism produces glucuronide metabolites, principally morphine-3-glucuronide and morphine-6-glucuronide. Impaired kidney function can cause these metabolites to accumulate, while liver disease can alter morphine clearance. These differences help explain why drug exposure and effects vary between patients. (dailymed.nlm.nih.gov)
Adverse effects and overdose
Adverse effects include nausea, vomiting, constipation, drowsiness, and low blood pressure. Serious toxicity may involve profound sedation, respiratory depression, coma, and death. Overdose can produce constricted pupils and cold, clammy skin, although individual signs are not sufficient to establish the diagnosis. (dailymed.nlm.nih.gov)
Other central nervous system depressants can intensify these effects. Important interactions include alcohol and benzodiazepines such as diazepam, with increased risks of respiratory depression, coma, and death. Prolonged exposure during pregnancy can cause neonatal opioid withdrawal. (dailymed.nlm.nih.gov)
Naloxone, an opioid antagonist, is used in the emergency treatment of opioid overdose. Antagonists can also precipitate withdrawal in a person who is physically dependent on opioids. (dailymed.nlm.nih.gov)
Tolerance, dependence, and addiction
These related concepts are not synonymous:
- Tolerance is reduced responsiveness after repeated exposure.
- Physical dependence is physiological adaptation that can produce withdrawal after abrupt discontinuation or a substantial reduction in exposure.
- Addiction, or opioid use disorder, involves impaired control and patterns of continued use despite harmful consequences.
Tolerance and physical dependence can develop during medical treatment and do not, by themselves, establish addiction. Morphine nevertheless carries addiction and misuse risks throughout treatment. (dailymed.nlm.nih.gov)
Regulation and access
In the United States, morphine is a Schedule II controlled substance: it has accepted medical uses but a high potential for abuse. (dea.gov)
The World Health Organization has included morphine in its Model List of Essential Medicines since the first edition in 1977. Its 2023 report documented substantial international inequalities in medical access. Morphine policy therefore encompasses both prevention of misuse and overdose and access to pain relief within functioning health systems. (who.int)
References
- Morphinedea.gov
- DailyMed — MORPHINE SULFATE tabletdailymed.nlm.nih.gov
- Morphine — PubChempubchem.ncbi.nlm.nih.gov
- The isolation of morphine by Serturnerpmc.ncbi.nlm.nih.gov
- Opium Poppymuseum.dea.gov
- Morphine Sulfate Tablets — Prescribing Informationdailymed.nlm.nih.gov
- DailyMed — MORPHINE SULFATE tablet, film coated, extended releasedailymed.nlm.nih.gov
- DailyMed — MORPHINE SULFATE injection, solutiondailymed.nlm.nih.gov
- DailyMed — MORPHINE SULFATE injectiondailymed.nlm.nih.gov
- Drug Fact Sheet: Morphinedea.gov
- Left behind in pain: Extent and causes of global variations in access to morphine for medical use and actions to improve safe accesswho.int
- People with medical needs are “left behind in pain” reveals new reportwho.int